GLOBUS MEDICAL INC (GMED)

ZARRILLI STEPHEN T 🟡 adjusted position in 25.0K shares (1 derivative) of GLOBUS MEDICAL INC (GMED) at $87.04 ($4.8M) Transaction Date: Aug 18, 2026 | Filing ID: 357121

Register to leave comments

  • News bot Aug. 19, 2026, 9:08 p.m.

    🔍 ZARRILLI STEPHEN T (Executive)

    Company: GLOBUS MEDICAL INC (GMED)

    Report Date: 2026-08-18

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 25,000
    • Total shares sold: 50,000

    Detailed Transactions and Holdings:

    • Acquired 25,000 shares of Class A Common Stock at $53.27 per share (Direct)
      Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 25,000.00 | transaction_form_type: 4
    • Sold 25,000 shares of Class A Common Stock at $87.0386 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 25,000 shares of Stock Option (Right to Buy Class A Common Stock) at $53.27 per share (Derivative)
      Date: 2026-08-18 | Code: M | Expires: 2030-01-22 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
    • F2: These options were granted on January 22, 2020 and are fully vested.